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459plaque volume, which had an area under the curve of
0.84 for predicting ACS, was not reported in this
study (2). This is of particular interest considering
recent studies that have demonstrated that low-
attenuated plaque burden improves determination
of functionally signiﬁcant stenosis by fractional ﬂow
reserve (5). It would have been of signiﬁcant interest
if quantitative plaque analysis was incorporated in
this study.
Lastly, the indication for 122 (49%) of patients to
serial CTA was for follow-up after percutaneous
coronary intervention. Could the authors clarify
whether this was performed for a clinical or research
indication?*Dennis T.L. Wong, MBBS (Hons)
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Monash University
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lesions. Radiology 2015;276:408–15.REPLY: Plaque Characterization by Coronary
Computed Tomography Angiography and
Association With Acute Coronary SyndromeWe thank Dr. Wong for the interest in our study (1)
and excellent suggestions. In our initial study
wherein we compared the culprit lesion of acute
coronary syndrome (ACS) with the target lesions in
stable angina (2), positive remodeling (PR), low-
attenuation plaques (LAP), and spotty calciﬁcationcharacterized the fateful plaques associated with
an acute coronary event. In our subsequent study (3),
we reported that PR and LAP plaques predicted
higher likelihood of acute coronary events during a
short-term follow up of 2 years. In the latter paper,
we also analyzed the relationship between spotty
calciﬁcation and acute coronary events; even though
the presence of spotty calciﬁcation was 2-fold higher
in the eventful compared with uneventful plaques,
the difference was statistically not signiﬁcant. On
the basis of this study, we deﬁned high-risk plaque
(HRP) as the 2-feature or 1-feature positive plaques
with PR and/or LAP in the latest study (1). In addition
to the higher likelihood of events arising from
HRP, we also observed that the period between the
computed tomography (CT) angiography and
the cardiac event associated with HRP was signiﬁ-
cantly shorter than the event arising from non-HRP
(1.7  1.8 vs. 3.4  2.4 years, p ¼ 0.0005). We agree
with Dr. Wong that the plaque volume, LAP volume,
and LAP area/plaque area as obtained in the intra-
vascular ultrasound studies (4) and as presented in
our previous study (3) should be included in CT
angiographic assessment. However, in our unpub-
lished experience, we have encountered napkin ring
sign (5) rather infrequently.
In the serial CT angiographic study, 122 patients
after percutaneous coronary intervention were eval-
uated for clinical indications such as the recurrence of
chest pain symptoms, or follow-up per discretion of
the physician. We excluded all the patients from
serial assessment who had sustained a cardiac event
before second CT angiogram was undertaken.Sadako Motoyama, MD, PhD*
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With Severe Aortic
Stenosis Deemed Extreme
Risk for Surgery
Appropriate?Aortic stenosis is the most common valve disease and
is expected to rise because of an increase in life ex-
pectancy. Although physicians have learned how to
care for critically ill old patients and enable many to
survive major surgical procedures, operating on pa-
tients at very high risk is often not appropriate or
technically feasible.
Given these considerations, we read with much
interest the recent paper and editorial by Yakubov
et al. (1) and Pilgrim and Windecker (2), respectively,
in the Journal evaluating the 2-year outcomes after
transfemoral self-expanding transcatheter aortic
valve replacement in 489 extreme-risk patients. They
found that the rate of all-cause mortality or major
stroke was 39% at 2 years. The rates of all-cause
mortality, cardiovascular mortality, and major
stroke were 36.6%, 26.2%, and 5.1 %, respectively, at 2
years. The multivariable predictors of all-cause mor-
tality at 2 years included the presence of coronary
artery disease and admission from an assisted living
facility. In addition, at 2 years, 94% of patients had
New York Heart Association functional class I to IIsymptoms. A beneﬁt of this size is remarkable given
the extreme-risk patient population that has been
included.
However, it is concerning that 42% of patients who
died between year 1 and year 2 did so from non-
cardiovascular causes. Additionally, in a separate
study looking at health status in the CoreValve
Extreme Risk Group, the proportion of patients with a
poor outcome was 39% at 6 months (22% death, 16%
very poor quality of life, and 1.4% quality-of-life
decline). In similar studies looking at 5-year out-
comes for the inoperable group of the PARTNER IB
trial (Placement of Aortic Transcatheter Valve Trial),
48% had multiple readmissions in the ﬁrst year
(readmission rates were not reported in this study)
(3). These observations suggest that frail elderly pa-
tients often have competing risks contributing to
their all-cause mortality. To treat one disease process,
only for another to take its place, should not be the
objective of an invasive expensive treatment with
complications. The total life expectancy now sur-
passes the extra years of life lived in good health in
high-income nations, and this difference continues to
widen (4). This aging population of patients with
more comorbidities may be at risk for overtreatment.
Now that the safety and efﬁcacy of transcatheter
aortic valve replacement is established, the current
research efforts have to reorient to appropriate pa-
tient selection.*Femi Philip, MD
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